Molecular Partners AG (MOLN)
NASDAQ: MOLN · IEX Real-Time Price · USD
7.00
-0.20 (-2.78%)
At close: Jul 2, 2024, 3:58 PM
6.87
-0.13 (-1.86%)
After-hours: Jul 2, 2024, 6:45 PM EDT

Molecular Partners AG Revenue

Molecular Partners AG had revenue of $7.64M in the twelve months ending March 31, 2024, down -64.99% year-over-year. Revenue in the quarter ending March 31, 2024 was $3.11M, a -7.17% decrease year-over-year. In the year 2023, Molecular Partners AG had annual revenue of $8.38M, a decrease of -95.89%.

Revenue (ttm)
$7.64M
Revenue Growth
-64.99%
P/S Ratio
30.39
Revenue / Employee
$45,768
Employees
167
Market Cap
232.27M USD

Revenue Chart

* The company reports in CHF currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.38M-195.49M-95.89%
Dec 31, 2022203.87M193.15M1,802.02%
Dec 31, 202110.72M100.50K0.95%
Dec 31, 202010.62M-10.40M-49.47%
Dec 31, 201921.01M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Auna SA 1.06B
AngioDynamics 324.01M
Sutro Biopharma 154.07M
Sanara MedTech 68.00M
Semler Scientific 65.88M
Aquestive Therapeutics 51.50M
Utah Medical Products 49.04M
Nyxoah 5.57M
Revenue Rankings